相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mutations in the Small GTPase Gene RAB39B Are Responsible for X-linked Mental Retardation Associated with Autism, Epilepsy, and Macrocephaly
Maila Giannandrea et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
NHS-A isoform of the NHS gene is a novel interactor of ZO-1
Shiwani Sharma et al.
EXPERIMENTAL CELL RESEARCH (2009)
X-linked cataract and Nance-Horan syndrome are allelic disorders
Margherita Coccia et al.
HUMAN MOLECULAR GENETICS (2009)
Adaptive evolution of SCML1 in primates, a gene involved in male reproduction
Hai-hui Wu et al.
BMC EVOLUTIONARY BIOLOGY (2008)
Prenatal detection of congenital bilateral cataract leading to the diagnosis of Nance-Horan syndrome in the extended family
Adi Reches et al.
PRENATAL DIAGNOSIS (2007)
Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes
Hilde Van Esch et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2007)
Nance-Horan syndrome protein, NHS, associates with epithelial cell junctions
Shiwani Sharma et al.
HUMAN MOLECULAR GENETICS (2006)
New mutations in the NHS gene in Nance-Horan Syndrome families from the Netherlands
Ralph J. Florijn et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
Rho GTPases, dendritic structure, and mental retardation
SE Newey et al.
JOURNAL OF NEUROBIOLOGY (2005)
EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2
JK Osterhoff et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Truncating mutation in the NHS gene: Phenotypic heterogeneity of Nance-Horan syndrome in an Asian Indian family
VL Ramprasad et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Identification of the gene for Nance-Horan syndrome (NHS)
SP Brooks et al.
JOURNAL OF MEDICAL GENETICS (2004)
Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation
KP Burdon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells
JK Oosterhoff et al.
ONCOGENE (2003)
分享论文
